SequelSEC

INNOSPEC INC. IOSP

Chemicals & Allied Products · CIK 0001054905 · Fiscal year ends 1231

Revenue
$1.84B
Fiscal year ended 2026-06-30
Operating income
$128.90M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

INNOSPEC INC. (IOSP) reported revenue of $1.84B for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from INNOSPEC INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Chemicals & Allied Products.

Income

INNOSPEC INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$1.84B
Cost of revenue$1.34B
Gross profit$505.90M
Operating income$128.90M
Net incomeUnavailable
Research & development$52.10M
Weighted-average diluted sharesUnavailable
Pretax income$143.30M
Income tax expense$21.00M
Diluted EPSUnavailable
Selling, general & administrative$304.00M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

INNOSPEC INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$250.20M
Total assets$1.85B
Current assets$1.02B
Total liabilities$495.20M
Current liabilities$368.10M
Total equity incl. NCI$1.35B
Temporary (mezzanine) equityUnavailable
Inventory$337.30M
Accounts receivable$408.60M
Goodwill$398.20M
Long-term debtUnavailable
Accounts payable$169.40M

Cash flow

INNOSPEC INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$124.30M
Capital expendituresUnavailable
Investing cash flow-$73.60M
Financing cash flow-$66.30M
Net change in cash-$16.40M
Stock-based compensation$7.80M
Common dividends paidUnavailable
Common share repurchases$24.10M
Depreciation & amortization$41.50M

Derived

INNOSPEC INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin27.5%
Operating margin7.0%
FCF marginUnavailable
SBC / revenue0.4%
Current ratio2.78x
Revenue YoY growth2.9%
Net marginUnavailable
R&D / revenue2.8%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rate14.7%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open IOSP in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-08View SEC filing
10-K · Filed 2026-02-18View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-09View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.